Current through Register Vol. 30, No. 50, December 13, 2024
Section R9-6-391 - Vancomycin-Resistant or Vancomycin-Intermediate Staphylococcus aureusCase control measures:
1. A diagnosing health care provider or an administrator of a health care institution, either personally or through a representative, shall isolate and implement contact precautions for a case or suspect case of vancomycin-resistant or vancomycin-intermediate Staphylococcus aureus.2. A diagnosing health care provider or an administrator of a health care institution transferring a known case with active infection or a known carrier of vancomycin-resistant or vancomycin-intermediate Staphylococcus aureus to another health care provider or health care institution shall, either personally or through a representative, comply with R9-6-305.3. A local health agency, in consultation with the Department, shall: a. Upon receiving a report under R9-6-202 of a case or suspect case of vancomycin-resistant or vancomycin-intermediate Staphylococcus aureus, notify the Department within one working day after receiving the report and provide to the Department the information contained in the report;b. Ensure that a case or suspect case of vancomycin-resistant or vancomycin-intermediate Staphylococcus aureus is isolated as necessary to prevent transmission;c. Conduct an epidemiologic investigation of each reported case or suspect case of vancomycin-resistant or vancomycin-inter-mediate Staphylococcus aureus;d. For each case of vancomycin-resistant or vancomycin-intermediate Staphylococcus aureus, submit to the Department, as specified in Table 2.4, the information required under R9-6-206(D); ande. Ensure that an isolate or a specimen, as available, from each case of vancomycin-resistant or vancomycin-intermediate Staphylococcus aureus is submitted to the Arizona State Laboratory.Ariz. Admin. Code § R9-6-391
Section R9-6-391 renumbered from R9-6-385and amended by final rulemaking at 14 A.A.R. 1502, effective April 1, 2008 (Supp. 08-2). Amended and renumbered from R9-6-386 by final rulemaking at 23 A.A.R. 2608, effective 1/1/2018.